SEC Tracker
Get the app

Spyre Therapeutics SYRE

Spyre Therapeutics (SYRE) reports insider sales.

Cameron Turtle, insider filing for SYRE

Form
4
Filed
Importance
Routine
  1. Cameron Turtle sold 14,561 shares on Oct 1, 2026.
  2. Selling price ranged from $88.63 to $93.91.
  3. Includes 29,078 shares vesting through November 2026.

Written from the Form 4 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Spyre Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Schrodinger SDGR public float $1.1B, Jun 30, 2025
  2. Mannkind MNKD public float $1.1B, Jun 30, 2025
  3. Novavax NVAX public float $1.0B, Jun 30, 2025
  4. Harrow HROW public float $1.0B, Jun 30, 2025
  5. Aurinia Pharmaceuticals AUPH public float $1.0B, Jun 30, 2025